Edition:
United States

Theraclion SA (ALTHER.PA)

ALTHER.PA on Paris Stock Exchange

4.89EUR
7:50am EDT
Change (% chg)

€0.02 (+0.41%)
Prev Close
€4.87
Open
€4.87
Day's High
€4.89
Day's Low
€4.86
Volume
2,316
Avg. Vol
10,574
52-wk High
€9.06
52-wk Low
€4.67

Latest Key Developments (Source: Significant Developments)

Theraclion FY net loss stable at 6.8 million euros
Monday, 27 Mar 2017 12:00pm EDT 

Theraclion SA : Theraclion presents its 2016 consolidated annual results . FY revenue 1.9 million euros ($2.1 million) versus 1.5 million euros year ago . FY operating loss of 7.8 million euros versus loss of 7.2 million euros year ago . FY net loss stable at 6.8 million euros (versus 6.4 million euros year ago) . At 31 december 2016, theraclion had available cash of eur 6,990,000 versus eur 3,753,000 at 31 december 2015 ."In 2017 we anticipate further growth in sales, in our installed base and in treatments, which already advanced strongly in 2016" - CEO.  Full Article

Theraclion 2016 sales of 1.9 million euros, up 8 pct
Friday, 3 Feb 2017 02:00am EST 

Theraclion SA : Growth continues in 2016 . 2016 sales of 1.9 million euros ($2.0 million), up 8 percent .In 2016 291 routine clinical treatments, up 300 percent compared to 2015.  Full Article

Theraclion signs two commercial agreements in Frankfurt for Echopulse systems
Monday, 9 Jan 2017 12:30pm EST 

Theraclion SA : Signs two commercial agreements in Frankfurt; first city with two Echopulse systems available for thyroid nodules .Biggest German insurer covers Echotherapy procedure.  Full Article

First acquisition of Theraclion's Echopulse in Switzerland
Thursday, 8 Dec 2016 05:40am EST 

Theraclion SA :Ente Ospedaliero Cantonale, Swiss group of centers of excellence, exercises option to buy Theraclion's echotherapy system.  Full Article

Theraclion launches 9.63 million euro capital increase
Monday, 25 Jul 2016 02:10am EDT 

Theraclion SA : Announced on Saturday it launches capital increase of 9.63 million euros ($10.57 million) with preferential subscription rights . Subscription ratio: 1 new share for every 3 existing shares . Subscription price: 5.98 euros per share . Subscription period: July 26 to August 5, 2016 .Existing investors and other shareholders of the Company have committed to subscribe for the capital increase for about 71.7 pct of the shares offered.  Full Article

Theraclion H1 revenue jumps 1,119 pct to 463,000 euros
Friday, 8 Jul 2016 02:00am EDT 

Theraclion SA : H1 revenue EUR 463,000 ($512,772.50) versus EUR 38,000 year ago .Says is actively looking for a future strategic partner to access the Chinese market, what could result in a creation of a joint venture.  Full Article

Theraclion announces that a hospital based Italy has signed a commercial agreement for use of Echopulse system
Wednesday, 29 Jun 2016 01:18pm EDT 

Theraclion Sa :Announces that A.S.L. 6 Di Livorno, a public hospital based in Tuscany, Italy, has signed a commercial agreement for use of Echopulse system.  Full Article

Theraclion signs commercial agreement with Klinikum Stephansplatz-Hamburg
Tuesday, 14 Jun 2016 01:13pm EDT 

Theraclion Sa :Klinikum Stephansplatz-Hamburg (Germany) has signed a commercial agreement and will now offer echotherapy to its patients.  Full Article

Theraclion enters commercial agreement with Tubingen University
Tuesday, 19 Apr 2016 11:40am EDT 

Theraclion SA:Tubingen University publishes positive results on echotherapy breast fibroadenoma clinical trial and enters a commercial agreement with Theraclion.  Full Article

Theraclion says new German nuclear medicine practice buys Echopulse system
Sunday, 3 Apr 2016 08:00pm EDT 

Theraclion SA:A new German nuclear medicine practice purchases Theraclion Echopulse system.  Full Article

More From Around the Web

BRIEF-Theraclion FY net loss stable at 6.8 million euros

* FY revenue 1.9 million euros ($2.1 million) versus 1.5 million euros year ago